<DOC>
	<DOC>NCT01668108</DOC>
	<brief_summary>The main purpose of this observational study with Paclitaxel is to determine the number of treatment cycles and the quantity of Paclitaxel onkovis needed therefore under the special circumstance of ambulant chemotherapy. onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective. Secondary objectives are the survey of the side effects of Paclitaxel onkovis in comparison to Docetaxel. To this purpose, data regarding co medications and adverse events are also collected.</brief_summary>
	<brief_title>A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Indication for Paclitaxel according to the SmPC and treating physician according to the Paclitaxel SmPC</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>carcinoma</keyword>
	<keyword>breast cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>ovarial cancer</keyword>
	<keyword>ambulant chemotherapy</keyword>
	<keyword>treatment cycles</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>Paclitaxel onkovis</keyword>
	<keyword>Quantity of Paclitaxel</keyword>
	<keyword>Packaging Sizes</keyword>
</DOC>